ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 198,696 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.00p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 5776 to 5799 of 8600 messages
Chat Pages: Latest  236  235  234  233  232  231  230  229  228  227  226  225  Older
DateSubjectAuthorDiscuss
08/7/2019
08:38
Well said, Featherby. It seems to me that regardless of the difficulties tiny companies face in bringing new drugs to market that N4P and Nuvec have never been in better shape:)))
ch1rp
06/7/2019
16:35
The particles were loaded incorrectly by an outsourced laboratory, admittedly sounds very amateurish but it’s now thankfully forced a credible action plan to ensure the successful in vivo test can and will be replicated positively as it HAS done before and eliminating such mistakes to be repeated.
It’s also worth noting this study will speed up additional studies with new collaborations starting on the strength of this work. Also fund raising is not an issue for the foreseeable future before anyone raises that problem, the budget for this upcoming works including manufacturing readiness at GMP standard which is critical for research growth is covered.

Not one large shareholder has sold any shares I also must highlight. I’m honestly trying hard not to be that ramper type that everyone hates but I do have to endorse the positives and correct the inaccurate.

featherby81
06/7/2019
16:09
But the technology has failed once so you have to worry about reproducibility. I worked on many programs where good results were not repeatable. It is the nature of science...
nobbygnome
06/7/2019
15:59
Current Market cap 5.3 million for what's on offer.
sbb1x
06/7/2019
11:52
And those developers will be paying N4 upfront, no risk to N4. If successful further royalties roll in! It’s a takeout dream
featherby81
06/7/2019
09:05
Well said Featherby81. I feel exactly the same about the Nuvec/ Nuvec story and am well invested. What I found particularly appealing was the high calibre of professionals who developed a suite of drugs that if, in any one of them made it passed trials and to market would make vast global sales. In this world it costs miles of money and time to bring these drugs to market and a little company like this with rock solid patents are hopefully, slowly but surely bringing them to market. Nuvec was always their ace in the pack, few substitutes and already proven in certain tests. I hope N4 will prove Nuvec to the world. Doing so would also allow them the possibility to develop the other drugs they have in their portfolio and for a tiny company in this world of pharmaceutical giants that would indeed be something.Here's to the day when we all see massive returns on our investment here:)))
ch1rp
05/7/2019
22:19
Nobby, you were absolutely spot on with Sildenafil and did warn the timings would be an issue sublingually.

Nuvec is a totally different concept and only a very small few have technology with similarities but still are having trouble which N4 might eventually overcome. What N4 and UQ have developed is potentially a milestone in vaccine development, you couldn’t deny that.

This early stage research is still a risk I admit and every investor ought to realise things can change in a split second, good or bad.

Myself and a number or serious investors joined N4 for the Nuvec/Nuvac story alone , it could be life changing for anyone holding a few thousand shares so I am keen to see this through until either commercial success or bankruptcy.

featherby81
05/7/2019
15:52
Leopards don't change their spots, but discredited tosspots do change their Twitter and advfn names..!
dplewis1
05/7/2019
15:34
>> featherby

I don't look at the thread very often as I am not invested any longer but maintain a historical interest so the timing of my posts is completely random. As you know there was one particular person who painted a completely naive and misleading story and I just gave the realistic, science based view. I will continue to do that and my perception is there is a massive risk here that essentially the company has a very unreliable technology which will never be fit for commercialisation. For me an awful lot of alarm bells have been ringing ever since the viagra disaster.

Leopards don't change their spots....

nobbygnome
05/7/2019
12:04
Mmmm many more buys than sells but down 4 pc???
ch1rp
05/7/2019
10:39
Buyers coming in, should get to at least 10p before results
sbb1x
05/7/2019
10:09
Last week we were talking about getting over 5p, well now it's here and maintaining a good base. This will build towards news whether Nobb wants it to or not:)))
ch1rp
05/7/2019
10:01
You never post on a day it’s rising Nobby, not having a pop just wondering.
featherby81
05/7/2019
09:40
The price reflects the risk. The evidence suggests the technology is not reliable and so the jury is out. There is a real chance they will get equivocal results from the ongoing experiments in which case it's all over bar the shouting IMHO.

Currently I wouldn't touch it with a barge pole....

nobbygnome
05/7/2019
09:30
Given the tech and the size of the future nano vaccine market (over $200b now possibly??) it wouldn’t be too boisterous to assume multiples of £100m mcap is what Nigel and crew are trying to eventually attain. It’s got a long way to go at current research stage but human trials will be the turning point for Nuvecs success, make or break!.
featherby81
05/7/2019
09:00
Market cap 5.5 million. If successful what's the value worth to the company....
sbb1x
05/7/2019
08:45
True, but it doesn't take away the fact that Nuvec has already passed the tests and results for the new batch of tests will be available in 2 months. Good news will rocket this share back to 30p and beyond. Watch as the BIG money buys in at these oversold levels:)))
ch1rp
04/7/2019
22:34
Some Twitter chunt claiming he bagged massive when this same chunt was buying 8s and 9s before the April updateforgot about them buysstupid chunt likes to big up imself, innit
dailylarma
04/7/2019
09:50
Slasher 81 on twitter yesterday This repeat test is extremely important as it provides the technical information (a handbook) for future collaborations or partners. If AZ or another huge player ain't showing interest before human trials begin it'll be THE share to be in!! #N4P
ch1rp
04/7/2019
08:44
Cant see any reason for this rise.Watching with interest!!!
billthebank
04/7/2019
08:33
Mms are fooling no one:)))
ch1rp
04/7/2019
08:29
You buyin’
escapetohome
04/7/2019
08:21
Don't need any ramps of other stock here.
soupdragon55
04/7/2019
07:49
Folks get in wrks net debt of £24m reansformed into net cash of £2.9m 495 stores dirextors all bought in yesterday only 63m shares hashtag wrks twitter
aladin1033
Chat Pages: Latest  236  235  234  233  232  231  230  229  228  227  226  225  Older

Your Recent History

Delayed Upgrade Clock